Changfeng Pharmaceuticals (02652.HK): NMPA has accepted the application for marketing approval of Salbutamol Inhalation Powder.

Zhtng Cijng APP xn, chngfng yoy (02652.HK) fb gnggo, bn gngs situ xi yn xr fn wj (gi chnpn) de shngsh xk shnqng y hu zhng hu rnmn gnghgu guji yopn jind gunl j (NMPA) shul. The Zhtng Finance and Economics APP newsflash, Changfeng Pharmaceuticals (02652.HK) announced that the company's application for the marketing approval of its saituo bromide inhalation powder spray (the product) has been accepted by the National Medical Products Administration of the People's Republic of China (NMPA).